Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TARPEYO safely and effectively. See full prescribing information for TARPEYO. TARPEYO (budesonide) delayed release capsules, for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
TARPEYO is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.
- generic_name
- budesonide
- product_names
- budesonide
- ndc
- 81749-004, 81749-004-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en